Cyclooxygenase-2 inhibitors: Will they help us prevent diabetic nephropathy?

This publication has 8 references indexed in Scilit:

• Cyclooxygenase-2 inhibitor blocks expression of mediators of renal injury in a model of diabetes and hypertension1
  Kidney International, 2002
• A comparison of renal-related adverse drug reactions between rofecoxib and celecoxib, based on the World Health Organization/Uppsala Monitoring Centre safety database
  Clinical Therapeutics, 2001
• Role of immunocompetent cells in nonimmune renal diseases
  Kidney International, 2001
• Cyclooxygenase-2 in the Kidney
  Journal of the American Society of Nephrology, 2000
• A selective cyclooxygenase-2 inhibitor decreases proteinuria and retards progressive renal injury in rats
  Kidney International, 2000
• Cyclooxygenase-2 Inhibition Decreases Renin Content and Lowers Blood Pressure in a Model of Renovascular Hypertension
  Hypertension, 1999
• Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction.
  Journal of Clinical Investigation, 1994
• Mechanical stretch/relaxation of cultured rat mesangial cells induces protooncogenes and cyclooxygenase
  American Journal of Physiology-Cell Physiology, 1994